Physiomics (PYC)

 

PYC Share PerformanceMore

52 week high0.0499 12/01/16
52 week low0.0198 19/10/16
52 week change -0.0150 (-42.86%)
4 week volume582,615,848 11/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Physiomics notes payment for in-silico modelling of inhibitor

Physiomics announces it is now entitled to a payment from Sareum Holdings for a three-month modelling project conduc...

Payment for in-silico modelling of inhibitor

RNS Number: 8909Q Physiomics PLC 05 December 2016 Physiomics Plc ("Physiomics" or "the Company") Payment for in-silico modelling of checkpoint inhibitor Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it is now entitled to a payment from Sareum Holdings plc ("Sareum") for a three month modelling...

Posting of Financial Results and Notice of AGM

RNS Number: 7370P Physiomics PLC 23 November 2016 Physiomics plc The Magdalen Centre The Oxford Science Park Robert Robinson Avenue Oxford OX4 4GA UK Tel 01865 784980 Fax 08701 671931 Physiomics plc ("Physiomics") or ("the Company") Dispatch of Annual Report and Shareholder Circular Proposed Share Consolidation Dispatch of Documentation P...

Provisional Award of Innovate UK Grant

RNS Number: 7373P Physiomics PLC 22 November 2016 Physiomics plc The Magdalen Centre The Oxford Science Park Robert Robinson Avenue Oxford OX4 4GA UK Tel 01865 784980 Fax 08701 671931 Physiomics plc ("Physiomics") or ("the Company") Provisional Award of Innovate UK Grant Physiomics plc (AIM: PYC), the Oxford, UK based systems biology com...

Physiomics turnover up 26%

Physiomics reports an operating loss of 431,561 for the year to the end of June - up from 414,755 in 2015. Turnover increased...

Final Results for the year ended 30 June 2016

RNS Number: 6529N Physiomics PLC 27 October 2016 27 October 2016 Physiomics Plc ("Physiomics" or "the Company") Final Results for the year ended 30 June 2016 Chairman's Statement Summary of Results in the year ended 30 June 2016 The turnover of the Company increased 26% to 297,120 (2015: 235,486) The loss after net operating expenses (excluding share-b...

Presentation at Conference on Pharmacometrics

RNS Number: 4250N Physiomics PLC 26 October 2016 Physiomics plc ("Physiomics") or ("the Company") Physiomics to give an oral presentation on developments of the Virtual Tumour platform in drug resistance at the Seventh American Conference on Pharmacometrics ("ACoP7") Physiomics plc (AIM: PYC), the Oxford, UK based systems biology Company, is p...

Physiomics notes directorate change

Physiomics said non-executive director Mark Chadwick will be leaving the company today, having served for six months ...

Fundamental DataMore

EPS-0.01
Dividend yield0 %

Equity Research (PYC)

Physiomics plc
01/11/2016
Following the decision not to proceed with the acquisition of oncology therapeutics Company BioMoti, Physiomics is now 100% focused on growing the revenues and creating a path to profitability in the...

Latest discussion posts More

  • 1/100 consolidation

    proposed for the 16th December
    24-Nov-2016
    1timco
  • auction

    gla :D
    9-Sep-2016
    etadelete
  • take off

    get in.sar on the move.could be news soon.gla
    21-Mar-2016
    etadelete

Users' HoldingsMore

Users who hold Physiomics also hold..
SAREUM21%
SOLO OIL19%
LLOYDS GRP.18%
VICTORIA OIL17%
RANGE RES.16%

Codes & Symbols

ISINGB00B04QT956
SymbolsPYC, LSE:PYC, PYC.L, PYC:LN, LON:PYC, XLON:PYC